VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $207,501 | -8.6% | 6,891 | -1.8% | 0.02% | -11.8% |
| Q1 2023 | $226,917 | -22.0% | 7,014 | -30.9% | 0.02% | -39.3% |
| Q4 2022 | $290,739 | +12.3% | 10,144 | -5.7% | 0.03% | +3.7% |
| Q3 2022 | $259,000 | -61.3% | 10,761 | -56.0% | 0.03% | -57.1% |
| Q2 2022 | $669,000 | -40.0% | 24,446 | -16.0% | 0.06% | -33.0% |
| Q1 2022 | $1,115,000 | -18.1% | 29,096 | -31.6% | 0.09% | -18.3% |
| Q4 2021 | $1,362,000 | +1.3% | 42,527 | -6.8% | 0.12% | -24.3% |
| Q3 2021 | $1,344,000 | -18.3% | 45,612 | -5.9% | 0.15% | -23.2% |
| Q2 2021 | $1,646,000 | +6.4% | 48,454 | +1.7% | 0.20% | -19.8% |
| Q1 2021 | $1,547,000 | +32.3% | 47,625 | +46.6% | 0.25% | +1.2% |
| Q4 2020 | $1,169,000 | +30.6% | 32,477 | +42.1% | 0.24% | +10.9% |
| Q3 2020 | $895,000 | +8.6% | 22,863 | +1.7% | 0.22% | -7.6% |
| Q2 2020 | $824,000 | – | 22,485 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |